Cutaneous pseudolymphoma successfully treated with dupilumab

Eur J Dermatol. 2023 Jun 1;33(3):307-309. doi: 10.1684/ejd.2023.4482.
No abstract available

MeSH terms

  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Humans
  • Pseudolymphoma* / drug therapy

Substances

  • dupilumab
  • Antibodies, Monoclonal, Humanized